Literature DB >> 6278500

Lymphocyte-conditioned medium protects human monocyte-macrophages from cholesteryl ester accumulation.

A M Fogelman, J Seager, M E Haberland, M Hokom, R Tanaka, P A Edwards.   

Abstract

Exposure of human monocyte-macrophages to as little as 50 microliters of cultured medium from lymphocytes stimulated by concanavalin A (Con A) resulted in a dramatic decrease in the activities of the low density lipoprotein (LDL) receptor pathway, the LDL-dextran sulfate pathway, and the scavenger receptor pathway. This effect was not seen when the monocyte-macrophages were exposed to culture medium from lymphocytes cultured without Con A or with Con A together with alpha-methyl mannoside or control medium without lymphocytes. The activity of 3-hydroxy-3-methyglutaryl-coenzyme A reductase also decreased in monocyte-macrophages exposed to culture medium from stimulated lymphocytes. Acyl-CoA:cholesterol O-acyltransferase activity, protein synthesis, protein content, phagocytosis of heat-killed yeast, and non-receptor-mediated endocytosis were not inhibited. Monocyte-macrophages exposed to malondialdehyde altered-LDL in the presence of stimulated lymphocyte culture medium accumulated substantially less cholesteryl esters than did cells in control medium. We propose that substances produced by stimulated lymphocytes may be useful in protecting macrophages from cholesteryl ester accumulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278500      PMCID: PMC345865          DOI: 10.1073/pnas.79.3.922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  A simple microscopic method for identifying and quantitating phagocytic cells in vitro.

Authors:  J Patterson-Delafield; R I Lehrer
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  Separation of and cholesterol synthesis by human lymphocytes and monocytes.

Authors:  A M Fogelman; J Seager; M Hokom; P A Edwards
Journal:  J Lipid Res       Date:  1979-03       Impact factor: 5.922

4.  Phospholipid distribution pattern in uninduced (resident) and casein-induced mouse peritoneal cells.

Authors:  E Kondo; K Kanai
Journal:  Jpn J Med Sci Biol       Date:  1977-10

5.  Abnormal induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia.

Authors:  A M Fogelman; J Edmond; J Seager; G Popják
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

6.  Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.

Authors:  R G Gerrity; H K Naito; M Richardson; C J Schwartz
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

7.  Mechanism of induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human leukocytes.

Authors:  A M Fogelman; J Seager; P A Edwards; G Popják
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

8.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

9.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

10.  Cholesterol metabolism in the macrophage. II. Alteration of subcellular exchangeable cholesterol compartments and exchange in other cell types.

Authors:  Z Werb; Z A Cohn
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

View more
  12 in total

1.  Human monocyte maturation/differentiation during in vitro culture.

Authors:  R A Musson
Journal:  Surv Immunol Res       Date:  1984

2.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.

Authors:  Y J Geng; G K Hansson
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Lipoproteins modulate expression of the macrophage scavenger receptor.

Authors:  J Han; A C Nicholson
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

4.  Dexamethasone modulates lipoprotein metabolism in cultured human monocyte-derived macrophages. Stimulation of scavenger receptor activity.

Authors:  L J Hirsch; T Mazzone
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells).

Authors:  M Lechleitner; B Auer; U Zilian; F Hoppichler; M Schirmer; B Föger; F Geisen; J R Patsch; G Konwalinka
Journal:  Lipids       Date:  1994-09       Impact factor: 1.880

6.  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.

Authors:  S E Roselaar; G Schonfeld; A Daugherty
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 7.  Gangliosides and atherosclerosis.

Authors:  N V Prokazova; L D Bergelson
Journal:  Lipids       Date:  1994-01       Impact factor: 1.880

8.  Participation of T lymphocytes in atherogenesis: sequential and quantitative observation of aortic lesions of rats with diet-induced hypercholesterolaemia using en face double immunostaining.

Authors:  S Haraoka; T Shimokama; T Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Attenuated combined action of cyclosporine a and hyperlipidemia on atherogenesis in rabbits by thymoquinone.

Authors:  Ahmed Ragheb; Ahmed Attia; Fawzy Elbarbry; Kailash Prasad; Ahmed Shoker
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-03       Impact factor: 2.629

10.  Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.

Authors:  P Lissoni; F Brivio; S Pittalis; M S Perego; A Ardizzoia; O Mauri; S Barni; S Crispino; G Tancini
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.